Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

128.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
128.8K
Depression: Overview01:18

Depression: Overview

571
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
571
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

278
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
278
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K
Long-term Depression01:05

Long-term Depression

32.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.4K
Long-term Depression01:03

Long-term Depression

2.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Innovative field diagnostics for real-time plant pathogen detection and management.

Frontiers in plant science·2026
Same author

Recent Advances on Application of Modified Biochar for the Removal of Pharmaceutical Compounds from Wastewater.

ChemistryOpen·2026
Same author

Thermal and storage degradation kinetics of corn anthocyanin-based natural red colorants in a model beverage system, and their gastrointestinal behavior.

NPJ science of food·2026
Same author

Multigene analysis reveals '<i>Candidatus</i> Phytoplasma asiaticum' (16SrII-C) association with niger and sesame phyllody in Madhya Pradesh, Central India and identification of a putative vector.

Frontiers in plant science·2026
Same author

Street women empowered and engaged to stop TB: A 'mixed method' study.

The Indian journal of tuberculosis·2026
Same author

Prescription pattern assessment of pharmacotherapeutics used in the management of amyloidosis secondary to rheumatoid arthritis via systematic review and network meta-analysis.

Journal of family medicine and primary care·2026
Same journal

Postoperative Impairment of GluA2 Ttrafficking in CA3 Induces Memory Consolidation Deficits in Aged Mice by Disrupting SPW-R in CA1.

Journal of molecular neuroscience : MN·2026
Same journal

MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy.

Journal of molecular neuroscience : MN·2026
Same journal

Notch Signaling Regulates the Neuroprotective Effects of hUCMSCs in a Mouse Model of Cerebral Ischemia.

Journal of molecular neuroscience : MN·2026
Same journal

Co-Administration of LPC and LPS Enhanced the Spinal Cord Vulnerability in a Mouse Model of Focal Demyelination.

Journal of molecular neuroscience : MN·2026
Same journal

Biomarker Based ARIA Stress Test: A Proposed Conceptual Framework for Dynamic Biomarker-Guided ARIA Risk Stratification in Anti-Amyloid Immunotherapy for Alzheimer's Disease.

Journal of molecular neuroscience : MN·2026
Same journal

The Association Between Alzheimer's Disease-Related Biomarkers And Parkinson's Disease Based On Single-Cell Sequencing Analysis Combined With Mendelian Randomization.

Journal of molecular neuroscience : MN·2026
See all related articles

Related Experiment Video

Updated: Nov 20, 2025

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.8K

Integrating Endocannabinoid Signalling In Depression.

Tarapati Rana1,2, Tapan Behl3, Aayush Sehgal2

  • 1Government Pharmacy College, Seraj, Mandi, Himachal Pradesh, India.

Journal of Molecular Neuroscience : MN
|January 20, 2021
PubMed
Summary
This summary is machine-generated.

The endocannabinoid system (ECS) shows promise as a biomarker for depression. Alterations in ECS function, particularly in the prefrontal cortex, are linked to depression, suggesting new therapeutic targets.

Keywords:
BiomarkerCB1 receptorsDepressionECSPsychiatric disorder

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

359
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

18.2K

Related Experiment Videos

Last Updated: Nov 20, 2025

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.8K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

359
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

18.2K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biomarker Research

Background:

  • Depression is a widespread mental disorder and a leading cause of suicide, posing diagnostic challenges due to its heterogeneity.
  • The prefrontal cortex (PFC) plays a crucial role in emotional and cognitive functions and is implicated in depressive disorders.
  • The endocannabinoid system (ECS) is increasingly recognized for its involvement in regulating brain functions relevant to mood and cognition.

Purpose of the Study:

  • To review the role of the endocannabinoid system (ECS) as a potential biomarker in depressive disorder.
  • To explore how key elements of the ECS, including endocannabinoids and CB1 receptors, function in the context of depression.
  • To assess the potential of targeting the ECS for novel therapeutic strategies in managing depression.

Main Methods:

  • Review of existing scientific literature on the endocannabinoid system and depression.
  • Analysis of studies investigating endocannabinoid concentrations and CB1 receptor activity in the prefrontal cortex of individuals with depression.
  • Examination of evidence from both animal and human studies on endocannabinoid signaling and depression-like behaviors.

Main Results:

  • Variations in endocannabinoid levels and CB1 receptor characteristics (binding affinity, density) have been observed in the PFC of individuals with depression.
  • Evidence suggests that altered endocannabinoid function contributes to the pathophysiology of depressive disorders.
  • Dysfunctional endocannabinoid signaling is linked to depression-like behaviors in preclinical and clinical studies.

Conclusions:

  • The endocannabinoid system presents a promising avenue for identifying biomarkers for depression.
  • Modulating endocannabinoid signaling may offer a novel therapeutic approach for treating depressive disorders.
  • Targeting the ECS could lead to more personalized and effective treatments for depression.